CMND stock news · Clearmind Medicine
Get alerts for CMND
Follow Clearmind Medicine (CMND) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CMND12 health care stocks are changing in price before the market opens, with NRX Pharmaceuticals going up and Acumen Pharmaceuticals dropping.
NeutralClearmind Medicine shares rose about 9% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
Shares of Clearmind Medicine decline on Friday following news of a $2.5 million acquisition of a 51% interest in Charging Robotics.
Bad for CMNDClearmind Medicine Inc. shares are trading lower as the company announced its acquisition of a 51% stake in Charging Robotics for $2.5 million, alongside a $1.5 million loan, indicating a strategic pivot from its traditional pharmaceutical operations.
Clinical trial for alcohol addiction treatment advances as Clearmind Medicine secures approval for patient testing.
Good for CMNDClearmind Medicine has made a significant advancement in its clinical trial for CMND-100, aimed at treating Alcohol Use Disorder, with the independent board approving the transition to patient testing. This progress is likely to enhance investor confidence and positively impact the stock price.